CN102977104A - Synthesis of 2,4-dichloro-7-hydroxy-pyrrolo(2,3)pyrimidine - Google Patents

Synthesis of 2,4-dichloro-7-hydroxy-pyrrolo(2,3)pyrimidine Download PDF

Info

Publication number
CN102977104A
CN102977104A CN2012104840057A CN201210484005A CN102977104A CN 102977104 A CN102977104 A CN 102977104A CN 2012104840057 A CN2012104840057 A CN 2012104840057A CN 201210484005 A CN201210484005 A CN 201210484005A CN 102977104 A CN102977104 A CN 102977104A
Authority
CN
China
Prior art keywords
limited
pyrrolo
degree
chloro
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012104840057A
Other languages
Chinese (zh)
Inventor
张福治
丁炬平
张仁延
余强
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cgenetech Suzhou China Co Ltd
Original Assignee
Cgenetech Suzhou China Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cgenetech Suzhou China Co Ltd filed Critical Cgenetech Suzhou China Co Ltd
Priority to CN2012104840057A priority Critical patent/CN102977104A/en
Publication of CN102977104A publication Critical patent/CN102977104A/en
Pending legal-status Critical Current

Links

Abstract

The invention discloses a synthesis method of 2,4-dichloro-7-hydroxy-pyrrolo(2,3)pyrimidine. According to the shortcomings that the traditional synthesis method of 2,4-dichloro-7-hydroxy-pyrrolo(2,3)pyrimidine has low reaction yield, requires strict conditions and does not easily realize purification, the invention proposes a way of cyclizing 1,3-dyhydroxy-5-aminophenylamine serving as an initial raw material with chloroacetaldehyde and then performing chlorination to obtain 2,4-dichloro-7-hydroxy-pyrrolo(2,3)pyrimidine; and the whole process has high yield, the operation is easy, the product is easy to purity, column chromatography is avoided, the method is suitable for industrialization, and the cost of raw materials is greatly reduced.

Description

Synthesizing of 2,4-, two chloro-7-hydrogen-pyrrolo-(2,3) pyrimidines
Technical field
The present invention relates to the synthetic of 2,4-, two chloro-7-hydrogen-pyrrolo-(2,3) pyrimidines, also relate to the synthetic of its intermediate and use, belong to medicine, chemical technology field.
Background technology
2,4-two chloro-7-hydrogen-pyrrolo-es (2,3) pyrimidine is important chemistry, and chemical intermediate is widely used in medicine and pesticide field, especially aspect antineoplastic new drug synthetic, be seen at present the analogue synthetic route of report seldom, and severe reaction conditions mostly, yield is low, be difficult for purifying, be difficult to industrialization.
Summary of the invention
It is low to the present invention is directed to 2,4-, two chloro-7-hydrogen-pyrrolo-(2,3) pyrimidines synthetic method reaction yield in the past, condition is harsh, is difficult for the deficiency of purifying, has invented described with 1,3-dihydroxyl-5-amino aniline is that starting raw material and monochloroacetaldehyde close ring, and chlorination obtains 2,4-, two chloro-7-hydrogen-pyrrolo-es (2 again, 3) route of pyrimidine makes whole process yield high, easy handling, the good purifying of product, avoid column chromatography, be fit to industrialization, raw materials cost reduces greatly.
Described 2,4-two chloro-7-hydrogen-pyrrolo-es (2,3) pyrimidine is synthetic, synthesize (2) used alkali including but not limited to sodium acetate, potassium acetate by 1,3-dihydroxyl-5-amino aniline and monochloroacetaldehyde reaction, sodium bicarbonate, yellow soda ash etc., first-selected sodium acetate, solvent is including but not limited to tetrahydrofuran (THF), dioxane, the mixing solutions of glycol dimethyl ether and water etc., first-selected solution is tetrahydrofuran (THF)/water=1:1, temperature of reaction is not limited to zero degree to 100 degree, time was not limited to 0.5 hour to 48 hours, wherein because of the chlorine activity of monochloroacetaldehyde a little less than, the catalyzer that adds activation includes but not limited to potassiumiodide, sodium iodide.
Described 2,4-two chloro-7-hydrogen-pyrrolo-(2,3) pyrimidines are synthetic, by synthetic 2,4-, two chloro-7-hydrogen-pyrrolo-(2, the 3) pyrimidines of intermediate (2) reaction, upper chlorine reagent is including but not limited to sulfur oxychloride, oxalyl chloride, phosphorus oxychloride, dichlorophenyl oxygen phosphorus etc., first-selected dichlorophenyl oxygen phosphorus, temperature of reaction is not limited to 25 degree to 250 degree, first-selected 180 degree, and the time is not limited to half an hour to 72 hour, first-selected 4 hours, the organic bases that wherein adds is including but not limited to triethylamine, diisopropyl ethyl amine, N, accelerine, N, N-Diethyl Aniline, first-selected diisopropyl ethyl amine.
Above-mentioned is that the chemical reaction route of starting raw material is as follows with 1,3-dihydroxyl-5-amino aniline:
Figure 678686DEST_PATH_IMAGE001
Embodiment
Preparation compound (2):
Starting raw material 1,3-dihydroxyl-5-amino aniline 250 grams (2.0 moles) are dissolved in tetrahydrofuran (THF)/water of 2.5 liters of 1:1, add the 50% monochloroacetaldehyde aqueous solution, 345.4 grams (2.2 moles), sodium acetate 328 grams (4.0 moles), potassiumiodide 0.5 gram, add rear room temperature reaction 24 hours, revolve tetrahydrofuran (THF), resistates is transferred PH to 11 with the sodium hydroxide of 1N, 1.5 liters of * 3 secondary clearings extractions of ethyl acetate, the organic phase washing, the saturated salt washing, anhydrous sodium sulfate drying filters, be spin-dried for, re-crystallizing in ethyl acetate obtains beige solid 256.7 grams (yield 85%).
Preparation compound (3) namely 2,4-two chloro-7-hydrogen-pyrrolo-(2,3) pyrimidines:
Compound (2) 151.1 grams (1.0 moles) that the upper step makes and dichlorophenyl oxygen phosphorus 429 grams (2.2 moles) and diisopropyl ethyl amine 222.2 grams (2.2 moles) mix; reaction solution is warmed up to 180 degree; reaction is 4 hours under the nitrogen protection; cool to room temperature; add 1 liter of anhydrous diethyl ether to resistates; stirred 1 hour, and filtered, vacuum-drying obtains pink solid 143.3 grams (yield 77%).
Do chlorinating agent with phosphorus oxychloride and prepare compound 2,4-two chloro-7-hydrogen-pyrrolo-(2,3) pyrimidines:
Compound (2) 151.1 grams (1.0 moles) that the upper step makes and phosphorus oxychloride 765 grams (5 moles) and diisopropyl ethyl amine 202.2 grams (2.0 moles) mix; reaction solution is warmed up to 130 degree; reaction is 24 hours under the nitrogen protection; cool to room temperature; evaporate excessive phosphorus oxychloride, add 1 liter of anhydrous diethyl ether to resistates, stirred 1 hour; filter, vacuum-drying obtains garnet solid 30.1 grams (yield 16%).

Claims (3)

1. described is that starting raw material and monochloroacetaldehyde close ring with 1,3-dihydroxyl-5-amino aniline, and chlorination obtains 2,4-, two chloro-7-hydrogen-pyrrolo-es (2 again, 3) route of pyrimidine makes whole process yield high, easy handling, the good purifying of product, avoid column chromatography, be fit to industrialization, raw materials cost reduces greatly.
2. described 2,4-two chloro-7-hydrogen-pyrrolo-es (2,3) pyrimidine is synthetic, synthesize (2) used alkali including but not limited to sodium acetate, potassium acetate by 1,3-dihydroxyl-5-amino aniline and monochloroacetaldehyde reaction, sodium bicarbonate, yellow soda ash etc., first-selected sodium acetate, solvent is including but not limited to tetrahydrofuran (THF), dioxane, the mixing solutions of glycol dimethyl ether and water etc., first-selected solution is tetrahydrofuran (THF)/water=1:1, temperature of reaction is not limited to zero degree to 100 degree, time was not limited to 0.5 hour to 48 hours, wherein because of the chlorine activity of monochloroacetaldehyde a little less than, the catalyzer that adds activation includes but not limited to potassiumiodide, sodium iodide.
3. described 2,4-two chloro-7-hydrogen-pyrrolo-(2,3) pyrimidines are synthetic, by synthetic 2,4-, two chloro-7-hydrogen-pyrrolo-(2, the 3) pyrimidines of intermediate (2) reaction, upper chlorine reagent is including but not limited to sulfur oxychloride, oxalyl chloride, phosphorus oxychloride, dichlorophenyl oxygen phosphorus etc., first-selected dichlorophenyl oxygen phosphorus, temperature of reaction is not limited to 25 degree to 250 degree, first-selected 180 degree, and the time is not limited to half an hour to 72 hour, first-selected 4 hours, the organic bases that wherein adds is including but not limited to triethylamine, diisopropyl ethyl amine, N, accelerine, N, N-Diethyl Aniline, first-selected diisopropyl ethyl amine.
CN2012104840057A 2012-11-26 2012-11-26 Synthesis of 2,4-dichloro-7-hydroxy-pyrrolo(2,3)pyrimidine Pending CN102977104A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012104840057A CN102977104A (en) 2012-11-26 2012-11-26 Synthesis of 2,4-dichloro-7-hydroxy-pyrrolo(2,3)pyrimidine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012104840057A CN102977104A (en) 2012-11-26 2012-11-26 Synthesis of 2,4-dichloro-7-hydroxy-pyrrolo(2,3)pyrimidine

Publications (1)

Publication Number Publication Date
CN102977104A true CN102977104A (en) 2013-03-20

Family

ID=47851495

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012104840057A Pending CN102977104A (en) 2012-11-26 2012-11-26 Synthesis of 2,4-dichloro-7-hydroxy-pyrrolo(2,3)pyrimidine

Country Status (1)

Country Link
CN (1) CN102977104A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104987339A (en) * 2015-07-29 2015-10-21 张燕梅 Synthesis method of tofacitinib citrate
CN114230572A (en) * 2021-12-24 2022-03-25 四川新迪医药化工有限公司 Preparation method of 2, 4-dichloro-7H-pyrrolo [2,3-D ] pyrimidine

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009037467A1 (en) * 2007-09-21 2009-03-26 Vernalis (R & D) Ltd. Pyrrolopyrimidine compounds
CN102131788A (en) * 2008-04-07 2011-07-20 Irm责任有限公司 Compounds and compositions as protein kinase inhibitors
WO2012051587A1 (en) * 2010-10-14 2012-04-19 Ariad Pharmaceuticals, Inc. Methods for inhibiting cell proliferation in egfr-driven cancers

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009037467A1 (en) * 2007-09-21 2009-03-26 Vernalis (R & D) Ltd. Pyrrolopyrimidine compounds
CN102131788A (en) * 2008-04-07 2011-07-20 Irm责任有限公司 Compounds and compositions as protein kinase inhibitors
WO2012051587A1 (en) * 2010-10-14 2012-04-19 Ariad Pharmaceuticals, Inc. Methods for inhibiting cell proliferation in egfr-driven cancers

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104987339A (en) * 2015-07-29 2015-10-21 张燕梅 Synthesis method of tofacitinib citrate
CN114230572A (en) * 2021-12-24 2022-03-25 四川新迪医药化工有限公司 Preparation method of 2, 4-dichloro-7H-pyrrolo [2,3-D ] pyrimidine

Similar Documents

Publication Publication Date Title
CN102584795A (en) Preparing method of crizotinib
CN105131017A (en) Preparation method for cefcapene pivoxil hydrochloride
CN103204823B (en) Method for purifying 1, 2-benzisothiazole-3-ketone
CN104130198B (en) 2-amino-4,6-dimethoxypyridin and preparation method thereof
CN102786491B (en) Preparation method of 2-methyl-4-isothiazolin-3-one
CN105566215A (en) Preparation method of Stivarga
CN102977104A (en) Synthesis of 2,4-dichloro-7-hydroxy-pyrrolo(2,3)pyrimidine
CN103965191A (en) Synthesis method of 6-bromoimidazo[1,2-alpha]pyridyl-3-formic acid
CN103626697B (en) A kind of preparation method of the cyanopyridine of 2 chlorine, 4 trifluoromethyl 3
CN106045914B (en) A kind of synthetic method of tri-substituted imidazoles
CN103896941A (en) Synthesis method of 6-chloroimidazo[1,2-a]pyridine-3-formonitrile
CN103724358A (en) Method for preparing (3aS, 6aR)-1, 3-dibenzyl-tetrahydro-4H-thieno [3, 4-d] imidazole-2, 4-(1H)-diketone
CN102936223A (en) Synthesis method and purification method of 5-iodo-2-methylbenzimidazole
CN105541724A (en) Preparation method of methimazole
CN108329276A (en) Hete rocyclic derivatives and its preparation and use
CN104910068A (en) 2-cyano isonicotinic acid hydrazide 1.5 p-toluenesulfonate synthetic method
CN103351346A (en) Preparation method of impurity HP1 in bendamustine hydrochloride
CN104151396B (en) The method that in the mixed solvent catalyzes and synthesizes S acetyl group L glutathione
CN106083631B (en) A kind of preparation method of equal amido phenenyl acid
CN102659713B (en) Preparation method for cefdinir side-chain acid active ester
CN105566350B (en) A kind of synthetic method of cefoperazone acid
CN103772282B (en) A kind of preparation method of the 3-tertiary butyl-1H-pyrazoles-4-formaldehyde
CN110294715B (en) Synthesis method of 2,4, 6-trichloro-5-methoxypyrimidine
CN103058934A (en) Synthesizing method of 5-acetyl-2,4-dichloropyrimidine
CN105175490A (en) Preparation method of argatroban intermediate

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20130320